Literature DB >> 1372276

Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

C Jhappan1, D Gallahan, C Stahle, E Chu, G H Smith, G Merlino, R Callahan.   

Abstract

Expression of the int-3 locus is activated in mouse mammary tumors as a consequence of insertional mutagenesis by the mouse mammary tumor virus (MMTV). Integration of the MMTV provirus into the int-3 locus promotes the transcription and translation of flanking cellular int-3 sequences sharing significant homology with the intracellular domain of the neurogenic Notch gene of Drosophila, and with the yeast cell cycle regulatory genes cdc10 and SWI6. To determine the in vivo consequences of activated int-3 expression, transgenic mice were generated harboring a genomic tumor DNA fragment consisting of the MMTV LTR and the flanking cellular int-3 sequences. All six int-3 founder transgenic mice and the progeny of one established line exhibited similar dramatic phenotypic abnormalities in tissues in which the transgene was expressed. Focal and often multiple poorly differentiated mammary and salivary adenocarcinomas appeared in the majority of transgenic mice between 2 and 7 months of age. Significantly, mammary glands were arrested in development and were lactation deficient in all female int-3 mice. The salivary glands, glands of the nasal mucosa and maxillary sinus, the extraorbital lacrimal glands, and the Harderian glands of juvenile and adult transgenic mice all contained proliferating immature ductule cells and were incompletely differentiated. In addition, all male int-3 transgenic mice were sterile, apparently the result of severe hyperplasia of the epididymis. These findings demonstrate in vivo that expression of the activated Notch-related int-3 gene causes deregulation of normal developmental controls and hyperproliferation of glandular epithelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372276     DOI: 10.1101/gad.6.3.345

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  122 in total

1.  SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; A Miyamoto; G Weinmaster; S D Hayward
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

Authors:  T Ohtsuka; M Ishibashi; G Gradwohl; S Nakanishi; F Guillemot; R Kageyama
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation.

Authors:  G Wu; S Lyapina; I Das; J Li; M Gurney; A Pauley; I Chui; R J Deshaies; J Kitajewski
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 4.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 5.  Notch and the awesome power of genetics.

Authors:  Iva Greenwald
Journal:  Genetics       Date:  2012-07       Impact factor: 4.562

Review 6.  Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

Authors:  Casper Groth; Mark E Fortini
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

7.  Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.

Authors:  Christine F O'Neill; Sumithra Urs; Christina Cinelli; Alexis Lincoln; Robert J Nadeau; Ruth León; Jessica Toher; Carla Mouta-Bellum; Robert E Friesel; Lucy Liaw
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

Review 8.  Paradigms of notch signaling in mammals.

Authors:  Alexis Dumortier; Anne Wilson; H Robson MacDonald; Freddy Radtke
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

9.  Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter.

Authors:  Ana R Raimondi; Lynn Vitale-Cross; Panomwat Amornphimoltham; J Silvio Gutkind; Alfredo Molinolo
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.